Policy

The value of the economic stimulus remains a hotly debated topic in the US, but the White House is claiming success in energy and other innovative fields.

Don’t punish companies that fail to deliver risky projects. Help them do better next time, says David Bott, Director of Innovation Programmes at the Technology Strategy Board.

The UK’s Human Genetic Commission has drawn up a set of principles for consumer gene testing that it hopes can form the basis of an international code of practice.

Frank Gannon, Director General of Science Foundation Ireland, is to leave his post a year early to become Director and CEO of the Queensland Institute of Medical Research.

Public spending on research has to stand up to rigorous economic scrutiny said the UK’s new Science Minister David Willetts, in a recent speech.

A partnership has been forged between the Wellcome Trust and the Department of Biotechnology in India to support the development of new healthcare products in India.

As it takes an axe to quangos from education to health, the UK government is laying plans for a new single body to supervise clinical trials.

Genomics is turbo-charging traditional plant and animal breeding. But can new varieties get patent protection, ask Nicholas Jones and Rachel Wallis of Withers & Rogers LLP.